Category: Clinical Trials
Ebola: Science Is Making Progress
Good news! Research on Ebola has identified a 100% effective vaccine and medications that produce a 90% survival rate.
Vitamin D and Diabetes: Another Case Where Supplementation Sounded Like a Good Idea But Wasn’t
A new study shows vitamin D supplements don't prevent diabetes. But there are still unanswered questions.
For-profit stem cell clinics, universities, and “pay-to-play” clinical trials for autism
Stem cell therapies show great promise, but as yet the vast majority of that promise has not been validated in rigorous clinical trials. Unfortunately, for-profit stem cell clinics are running clinical trials that require patients to pay to be part of it. These trials are not rigorous. Even more unfortunately, it appears that some universities are also running "pay-to-play" clinical trials that...
Vyleesi: New Drug for Hypoactive Sexual Desire in Women
New drug to treat hypoactive sexual desire in women, Vyleesi, is not very effective and has several drawbacks. It is NOT Viagra for women.
Medicare proposal covers acupuncture for back pain study participants: A prelude to full coverage?
Medicare coverage of acupuncture is under consideration. A new proposal would provide coverage to Medicare patients participating in studies of acupuncture for back pain. This research would be used in making a final decision.
New Drug Is Effective for Post-Partum Depression, But There Are Drawbacks
A new drug promises to cure postpartum depression, but it is restricted and patients must be hospitalized for a 60-hour IV infusion.
“Young blood” infusions: same old snake oil
There's no reliable evidence that an infusion of blood plasma from a young donor will benefit an older person, and there are risks, but Ambrosia Health is selling "young blood" infusions for thousands of dollars anyway. The FDA has taken notice.
Dubious for-profit stem cell clinics: Co-opting ClinicalTrials.gov as a marketing tool
Over twenty years ago, cancer quack Stanislaw Burzynski pioneered the abuse of the clinical trial process as a marketing tool to sell his antineoplastons. Now, for-profit stem cell clinics are using ClinicalTrials.gov as a marketing tool for their unproven therapies by listing dubious and scientifically worthless trials in this government database. What can be done?
The FDA’s accelerated drug approval program is failing to protect cancer patients
Drug approval is a process that should be and, for the most part, is rooted in rigorous science. However, there is always a countervailing pressure to approve new drugs rapidly, particularly in cancer. That's why the FDA created the accelerated approval program in the early 1990s. Unfortunately, increasingly this approval process appears to be failing us in oncology. Reform is needed.
Stem Cells for Knee Arthritis
Stem cell treatments for knee arthritis are not yet ready for prime time, but that has not stopped their premature commercialization.